Picture of Siegfried Holding AG logo

SFZN Siegfried Holding AG Share Price

0.000.00%
ch flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+6.31%
3m-4.92%
6m-18.53%
1yr+4.22%
Volume Change (%)
10d/3m-8.47%
Price vs... (%)
52w High-23.57%
50d MA-1.48%
200d MA-11.97%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)22.19
PEG Ratio (f)2.86
EPS Growth (f)8.41%
Dividend Yield (f)0.49%
Valuation (ttm)IndustryMarket
Price to Book Value4.05
Price to Tang. Book4.3
Price to Free Cashflown/a
Price to Sales3.07
EV to EBITDA15.58

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital12.25%
Return on Equity17.56%
Operating Margin15.39%

Financial Summary

Year End 31st DecUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueCH₣m845.061,102.421,229.521,271.491,294.571,368.861,479.139.21%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+16.68+83.25+59.8-27.92+37.99+6+13.3n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Siegfried Holding AG EPS forecast chart

Profile Summary

Siegfried Holding AG is a Switzerland-based life sciences company which is active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and sterile. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States, China, and Spain.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
December 27th, 1904
Public Since
January 1st, 1973
No. of Shareholders
8,752
No. of Employees
3,886
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ch flag iconSIX Swiss Exchange
Shares in Issue
4,376,827

SFZN Share Price Performance

Upcoming Events for SFZN

Half Year 2025 Siegfried Holding AG Earnings Release

Similar to SFZN

Picture of Cosmo Pharmaceuticals NV logo

Cosmo Pharmaceuticals NV

ch flag iconSIX Swiss Exchange

Picture of Curatis Holding AG logo

Curatis Holding AG

ch flag iconSIX Swiss Exchange

Picture of Dottikon Es Holding AG logo

Dottikon Es Holding AG

ch flag iconSIX Swiss Exchange

Picture of Galenica AG logo

Galenica AG

ch flag iconSIX Swiss Exchange

Picture of Novartis AG logo

Novartis AG

ch flag iconSIX Swiss Exchange

FAQ